Groundbreaking Findings at the International Stroke Conference Highlight Brainomix 360 Innovations
Recently, at the International Stroke Conference (ISC) held in Los Angeles, Brainomix introduced a series of compelling studies showcasing the transformative impact of its Brainomix 360 system on stroke treatment. With stroke care being a critical area for advancement, Brainomix's contributions underline its commitment to harnessing artificial intelligence to improve patient outcomes and expand access to essential interventions.
The Brainomix 360 platform, which is fully cleared by the FDA, operates on advanced AI algorithms. Notably, the system includes the e-ASPECTS module—a patented tool that analyzes non-contrast CT scans to automatically determine an ASPECTS score. This scoring system is crucial for identifying eligibility for endovascular treatment in cases of large vessel occlusion (LVO). The American Heart Association has recently updated its guidance, underscoring the importance of ASPECTS scoring as the primary imaging criterion for assessing patients.
At the ISC, significant findings were shared from a study that evaluated real-world applications of Brainomix 360, incorporating data from over 71,000 patients across 26 hospitals over a three-year period. The results were nothing short of impressive—hospitals utilizing Brainomix 360 reported a doubling of their thrombectomy rates during the evaluation period, with a 37% increase compared to institutions not using the system. Additionally, these facilities experienced a remarkable acceleration in their door-in-door-out (DIDO) times, improving by an average of 65 minutes. This efficiency is critical in the fast-paced context of stroke treatment, where timely intervention is vital to patient recovery.
Dr. George Harston, Chief Medical Innovation Officer at Brainomix, emphasized the groundbreaking nature of these results, which reinforce the system’s effectiveness in enhancing stroke care. He noted that data from US stroke networks showcased similarly significant outcomes, including improved thrombolysis rates at the Mayo Clinic when using Brainomix 360 across its telestroke network. It became evident that the integration of AI in stroke management not only sped up treatment times but also bolstered healthcare professionals' confidence in their diagnosis and treatment decisions.
Apart from the compelling data presented, Brainomix's collaboration with leading academic stroke institutions has also yielded deeper insights into stroke pathophysiology. Dr. Waleed Brinjikji of the Mayo Clinic commented on their longstanding partnership with Brainomix, highlighting how their AI algorithms have facilitated groundbreaking research into brain frailty and eloquence. These discoveries pave the way for potentially new and optimized patient selection strategies within stroke care.
As the conference progressed, Brainomix hosted various presentations and poster sessions to share their research findings. Participants learned about the significant influence of AI on acute ischemic stroke treatment, discussing topics such as the predictive capabilities of imaging techniques and the implications of rapid decision-making in clinical settings, providing practitioners with the tools necessary to improve their decision-making processes in the treatment of strokes.
Brainomix's innovative approach exemplifies the ongoing evolution of stroke care, demonstrating how AI technologies can make substantial differences in real-world medical practices. As healthcare professionals continue to face the challenges of stroke management, the implementation of intelligent imaging systems like Brainomix 360 stands poised to lead the way towards improved patient outcomes and more efficient treatment paths. With its latest advancements, Brainomix not only reinforces its position as a leader in AI imaging solutions but also significantly contributes to the future of stroke treatment and patient care on a global scale.
For more insights into the efficacy of AI in improving healthcare practices, following Brainomix’s developments can provide valuable knowledge and potentially influence future medical standards in stroke treatment modalities. Their relentless pursuit of innovation reflects a vision where advanced technology significantly enhances clinical outcomes and patient quality of life.
The Brainomix 360 platform, which is fully cleared by the FDA, operates on advanced AI algorithms. Notably, the system includes the e-ASPECTS module—a patented tool that analyzes non-contrast CT scans to automatically determine an ASPECTS score. This scoring system is crucial for identifying eligibility for endovascular treatment in cases of large vessel occlusion (LVO). The American Heart Association has recently updated its guidance, underscoring the importance of ASPECTS scoring as the primary imaging criterion for assessing patients.
At the ISC, significant findings were shared from a study that evaluated real-world applications of Brainomix 360, incorporating data from over 71,000 patients across 26 hospitals over a three-year period. The results were nothing short of impressive—hospitals utilizing Brainomix 360 reported a doubling of their thrombectomy rates during the evaluation period, with a 37% increase compared to institutions not using the system. Additionally, these facilities experienced a remarkable acceleration in their door-in-door-out (DIDO) times, improving by an average of 65 minutes. This efficiency is critical in the fast-paced context of stroke treatment, where timely intervention is vital to patient recovery.
Dr. George Harston, Chief Medical Innovation Officer at Brainomix, emphasized the groundbreaking nature of these results, which reinforce the system’s effectiveness in enhancing stroke care. He noted that data from US stroke networks showcased similarly significant outcomes, including improved thrombolysis rates at the Mayo Clinic when using Brainomix 360 across its telestroke network. It became evident that the integration of AI in stroke management not only sped up treatment times but also bolstered healthcare professionals' confidence in their diagnosis and treatment decisions.
Apart from the compelling data presented, Brainomix's collaboration with leading academic stroke institutions has also yielded deeper insights into stroke pathophysiology. Dr. Waleed Brinjikji of the Mayo Clinic commented on their longstanding partnership with Brainomix, highlighting how their AI algorithms have facilitated groundbreaking research into brain frailty and eloquence. These discoveries pave the way for potentially new and optimized patient selection strategies within stroke care.
As the conference progressed, Brainomix hosted various presentations and poster sessions to share their research findings. Participants learned about the significant influence of AI on acute ischemic stroke treatment, discussing topics such as the predictive capabilities of imaging techniques and the implications of rapid decision-making in clinical settings, providing practitioners with the tools necessary to improve their decision-making processes in the treatment of strokes.
Brainomix's innovative approach exemplifies the ongoing evolution of stroke care, demonstrating how AI technologies can make substantial differences in real-world medical practices. As healthcare professionals continue to face the challenges of stroke management, the implementation of intelligent imaging systems like Brainomix 360 stands poised to lead the way towards improved patient outcomes and more efficient treatment paths. With its latest advancements, Brainomix not only reinforces its position as a leader in AI imaging solutions but also significantly contributes to the future of stroke treatment and patient care on a global scale.
For more insights into the efficacy of AI in improving healthcare practices, following Brainomix’s developments can provide valuable knowledge and potentially influence future medical standards in stroke treatment modalities. Their relentless pursuit of innovation reflects a vision where advanced technology significantly enhances clinical outcomes and patient quality of life.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.